Fresenius aims to float all its divisions - starting with Kabi
This article was originally published in Clinica
Executive Summary
German company Fresenius plans to list its separate divisions, starting with its nutrition and infusion therapies unit, Fresenius Kabi, which may be floated as early as next year.